Faculty
Education
PhD Epidemiology, University of Washington, 2010
MPH Infectious Diseases, University of California (Berkeley), 2002
BS Physiology, University of California (Santa Barbara), 1998
Contact
WA
Bio
Dr. Sangaré is the principal epidemiologist at EpiAdvantage, a specialized consulting firm providing professional services in epidemiology to law firms as well as to pharmaceutical and biotechnology companies. She is an experienced consultant with over 20 years of experience partnering with pharmaceutical and biotechnology companies, consulting groups, and attorneys. Her projects have spanned both academia and industry, in the US and abroad.
Research Areas
Research Interests
Forensic epidemiology, infectious diseases, perinatal epidemiology, global health, malaria, and maternal and child health.
Recent Publications (PubMed)
Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study.
(2024 Jul)
Lung Cancer 193(): 107819
Borghaei H, Pundole X, Sangaré L, Anderson E, Bebb DG, Jiang T, Pastel M, Carrigan G, Balasubramanian A, Martinez P, Ramalingam SS
(2024 Jul)
Lung Cancer 193(): 107819
Borghaei H, Pundole X, Sangaré L, Anderson E, Bebb DG, Jiang T, Pastel M, Carrigan G, Balasubramanian A, Martinez P, Ramalingam SS
Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non-Carfilzomib-Based Regimens in the United States by Race.
(2023 Aug)
Clin Lymphoma Myeloma Leuk 23(8): 616-625
Li S, Suehs BT, Fu A, Sangaré L, Kim C, Gastanaga VM, Liu J, Yan H, Xu Y, Mikhael J
(2023 Aug)
Clin Lymphoma Myeloma Leuk 23(8): 616-625
Li S, Suehs BT, Fu A, Sangaré L, Kim C, Gastanaga VM, Liu J, Yan H, Xu Y, Mikhael J
Navigating metastatic colorectal treatment options in the USA: a survey of patient acceptance of skin toxicities associated with Vectibix.
(2021 Nov)
Support Care Cancer 29(11): 6731-6740
Sangaré L, Divita A, Rehn M, McNamara M, Lowe KA
(2021 Nov)
Support Care Cancer 29(11): 6731-6740
Sangaré L, Divita A, Rehn M, McNamara M, Lowe KA
An evaluation of RAS testing among metastatic colorectal cancer patients in the USA.
(2021 May)
Future Oncol 17(13): 1653-1663
Sangaré L, Delli-Zotti K, Florea A, Rehn M, Benson AB, Lowe KA
(2021 May)
Future Oncol 17(13): 1653-1663
Sangaré L, Delli-Zotti K, Florea A, Rehn M, Benson AB, Lowe KA
Occurrence and Management of Thrombocytopenia in Metastatic Colorectal Cancer Patients Receiving Chemotherapy: Secondary Analysis of Data From Prospective Clinical Trials.
(2021 Jun)
Clin Colorectal Cancer 20(2): 170-176
Kilpatrick K, Shaw JL, Jaramillo R, Toler A, Eisen M, Sangaré L, Soff GA
(2021 Jun)
Clin Colorectal Cancer 20(2): 170-176
Kilpatrick K, Shaw JL, Jaramillo R, Toler A, Eisen M, Sangaré L, Soff GA
Show complete publication list